Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000246418 | SCV000319067 | likely benign | Cardiovascular phenotype | 2013-11-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001083135 | SCV000555323 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000728842 | SCV000716380 | likely benign | not provided | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000728842 | SCV000856460 | uncertain significance | not provided | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000728842 | SCV001747988 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000614907 | SCV005039451 | likely benign | not specified | 2024-03-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000614907 | SCV001922513 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000728842 | SCV001927579 | likely benign | not provided | no assertion criteria provided | clinical testing |